Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMSVQMO)

Drug Name	PMID25656651-Compound-31a Drug Info
Cross-matching ID	PubChem CID 56599744 TTD Drug ID DMSVQMO

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Patented Agent(s)

Download the Complete Related Drug List

Drug(s) Targeting Fusion protein Bcr-Abl T315I mutant (Bcr-Abl T315I)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
PMID25656651-Compound-37b	DMX98YV	N. A.	N. A.	Patented	[1]
PMID25656651-Compound-36a	DMNXVY9	N. A.	N. A.	Patented	[1]
PMID25656651-Compound-37c	DM684IK	N. A.	N. A.	Patented	[1]
PMID25656651-Compound-36d	DMKMY4I	N. A.	N. A.	Patented	[1]
PMID25656651-Compound-36b	DMHYDM7	N. A.	N. A.	Patented	[1]
PMID25656651-Compound-36c	DMOGKSW	N. A.	N. A.	Patented	[1]
PMID25656651-Compound-19b	DMI1Z7D	N. A.	N. A.	Patented	[1]
PMID25656651-Compound-37a	DM0P4F3	N. A.	N. A.	Patented	[1]
PMID25656651-Compound-19a	DMSNUVZ	N. A.	N. A.	Patented	[1]
Indazole derivative 5	DMM1I8R	N. A.	N. A.	Patented	[1]
------------------------------------------------------------------------------------


⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Fusion protein Bcr-Abl T315I mutant (Bcr-Abl T315I)	TTIV39N	BCR_HUMAN-ABL1_HUMAN	Inhibitor	[1]

------------------------------------------------------------------------------------

References

1	Bcr-Abl tyrosine kinase inhibitors: a patent review.Expert Opin Ther Pat. 2015 Apr;25(4):397-412.